You can install PPMD to make it easier to access on your device. A network connection is still required to view medication and interaction information.
You should now see a icon on your home screen.
Tap then menu button, and then tap Install.
Not all web browsers and platforms support progressive web applications (PWA). Consult the documentation for your web browser for additional assistance.
N/A
In single-center, open-label, two-period, single sequence study, 18 hepatitis C virus (HCV)-negative adults on stable opiate maintenance therapy with methadone (20-150 mg daily) received danoprevir/ritonavir (DNV/r) 100/100 mg twice daily for 10 days.
Coadministration of DNV/r (100/100mg twice daily) for 10 days did not significantly impact the pharmacokinetics (PK) of both R- (active enantiomer) and S- methadone. Geometric mean ratios (GMRs; DNV/r + methadone / methadone) [90% CIs] of AUC and Cmax for R-methadone were 1.02 [0.91, 1.15] and 1.01 [0.90, 1.13], respectively; GMRs (DNV/r + methadone / methadone) [90% CIs] of AUC and Cmax for S-methadone were 1.01 [0.93, 1.13] and 0.99 [0.89, 1.10], respectively.No symptoms of opiate toxicity or withdrawal were noted.
Moreira SA, Morcos PN, Navarro MT, et al. No change in steady state pharmacokinetics of methadone after coadministration with danoprevir/ritonavir [abstract pk_10]. 7th Annual International Workshop On Clinical Pharmacology Of Hepatitis Therapy. Cambridge, MA. ; 2012.